Comparative biodistributions of indium-111-labelled macrocycle chimeric B72.3 antibody conjugates in tumour-bearing mice
Open Access
- 1 July 1994
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 70 (1) , 35-41
- https://doi.org/10.1038/bjc.1994.246
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- A single amino acid substitution abolishes the heterogeneity of chimeric mouse/human (IgG4) antibodyMolecular Immunology, 1993
- Engineering Antibodies for TherapyImmunological Reviews, 1992
- Development of humoral immune responses against a macrocyclic chelating agent (DOTA) in cancer patients receiving radioimmunoconjugates for imaging and therapy.1992
- Detection of hepatic metastases from colorectal carcinoma using indium-111 (111In) labeled monoclonal antibody (mAB): MSKCC experience with mAb 111In-C110International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, 1991
- Diagnostic evaluation of 111In and 99mTc radiolabelled monoclonal antibodies in ovarian and colorectal cancer: Correlations with surgeryInternational Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, 1991
- Site-specific attachment to recombinant antibodies via introduced surface cysteine residuesProtein Engineering, Design and Selection, 1990
- CHARACTERIZATION AND BIODISTRIBUTION OF RECOMBINANT AND RECOMBINANT CHIMERIC CONSTRUCTS OF MONOCLONAL-ANTIBODY B72.31989
- Development of a metastatic human colon cancer xenograft model in the nude mouseJournal of Surgical Oncology, 1986
- Conjugation of antibodies with bifunctional chelating agents: Isothiocyanate and bromoacetamide reagents, methods of analysis, and subsequent addition of metal ionsAnalytical Biochemistry, 1984
- The preparation of DTPA-coupled antibodies radiolabeled with metallic radionuclides: an improved methodJournal of Immunological Methods, 1983